THE TRUTH ABOUT: 16 - The Untold Story

Novo Nordisk Poised For UNH-Style Comeback: New Data & AI Boost Signal Reversal

Novo Nordisk A/S (NYSE:NVO) looks ready to shake off its slump. With weight-loss pills showing blockbuster results, Ozempic proving heart-healthy benefits, and analysts flipping bullish, the stock is starting to resemble UnitedHealth Group Inc.'s (NYSE:UNH) rebound playbook.

Benzinga · Sep 18, 2025

Short Report Alleges Dexcom Sold Faulty G7 Device Cited By FDA

Hunterbrook Media released a short report on diabetes-focused DexCom Inc. (NASDAQ:DXCM), citing that the company sold the "adulterated" device.

Benzinga · Sep 18, 2025

‘Pioneering’ new weight-loss jab could help keep weight off even after you stop taking it

The downfall of drugs such as Mounjaro, Ozempic and Wegovy is many patients regain weight shortly after stopping

The Independent UK · Sep 17, 2025

Wegovy's Next Step: Novo Nordisk Eyes Approval for Higher-Dose Treatment

Novo Nordisk A/S (NYSE:NVO) reportedly said on Tuesday that it intends to seek US regulatory approval for a high-dose version of its weight-loss injection Wegovy (semaglutide), another effort to counter Eli Lilly and Co. (NYSE:LLY).

Benzinga · Sep 16, 2025

Weight loss jabs could be effective on children as young as six, study suggests

The report did warn that stomach problems are more common among youngsters taking the drugs.

Evening Standard · Sep 15, 2025

Obese children as young as six could benefit from weight-loss jabs

About a third of children leaving primary school are overweight or living with obesity in England

The Independent UK · Sep 15, 2025

More of the world's children are obese than underweight, UN warns

For the first time, more school-aged children are obese than underweight around the world, with the exception of sub-Saharan Africa and South Asia. The warning came in a report released on Wednesday by the United Nations children’s agency Unicef.

Radio France Internationale · Sep 10, 2025

Why have energy drinks been banned for under-16s in England? The real question is why it wasn’t done sooner

Expecting parents to police kids’ intake of a psychoactive drug is unrealistic and unfair given the power of social media, says Prof Devi Sridhar, chair of global public health at the University of Edinburgh

The Guardian - UK · Sep 10, 2025

More children now obese than underweight for first time ever

Major study by Unicef finds 391 million children across the globe now overweight or obese

The Independent UK · Sep 10, 2025

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

The Independent UK · Sep 10, 2025